Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT03906305
Eligibility Criteria:
Inclusion Criteria:
* Medical diagnosis of unilateral ischemic Stroke
* Unilateral hemiplegia resulting from Stroke
* Evolution of at least 6 months since the Stroke
* Age between 35 and 81 years of age
* Presence of hypertonia in the upper extremity
* Restricted shoulder range of motion
Exclusion Criteria:
* Recurrent Stroke
* Previous treatment with nerve blocks, motor point injections with neurolytic agents for Spasticity at any time, or with BTX-A in the previous 6 months
* Cognitive deficits
* Progressive or severe neurological diseases, eg, heart conditions, unstable hypertension, fractures or implants in upper extremity
* Belonephobia (fear to needles)
* Have received pharmacological treatment for shoulder pain 3 months before the study
* Existence of peripheral nerve injury
* Previous history of fracture in the gleno-humeral joint
* Episodes of epilepsy in the year prior to participation in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
81 Years
Study:
NCT03906305
Study Brief:
Protocol Section:
NCT03906305